Affiliation:
1. Department of Respiratory Medicine , Hospital Universitario La Paz, Instituto de investigación del Hospital Universitario La Paz (IdiPAZ) , Madrid , Spain
Abstract
Abstract
Cystic fibrosis is the most common autosomal recessive disease in the Caucasian race. Its course is chronic and progressive, with pulmonary involvement being associated with greater morbidity and mortality. One of the factors most related to worse prognosis in these patients is respiratory exacerbations. Although limited, there is evidence demonstrating that increased exposure to environmental pollution, both acute and chronic, is associated with an increase in these exacerbations. It is crucial to fully understand this relationship in order to attempt to improve the respiratory health of these patients. That is why the available evidence is reviewed and measures are established to reduce exposure to pollutants.
Reference39 articles.
1. Grasemann, H, Ratjen, F. Cystic fibrosis. N Engl J Med. 2023;389:1693–707. https://doi.org/10.1056/nejmra2216474.
2. Corriveau, S, Sykes, J, Stephenson, AL. Cystic fibrosis survival: the changing epidemiology. Curr Opin Pulm Med 2018;24:574–8. https://doi.org/10.1097/mcp.0000000000000520.
3. Spanish Cystic Fibrosis Society, Registry Group. Spanish cystic fibrosis Registry: report 2019; 2022. [Internet]. Available from: https://fibrosisquistica.org/wp-content/uploads/2022/11/Report2019-Definitivo.pdf.
4. Coriati, A, Ma, X, Sykes, J, Stanojevic, S, Ruseckaite, R, Lemonnier, L, et al.. Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand. Thorax 2023;78:242–8. https://doi.org/10.1136/thorax-2022-219086.
5. Blayac, M, Coll, P, Urbach, V, Fanen, P, Epaud, R, Lanone, S. The impact of air pollution on the course of cystic fibrosis: a review. Front Physiol 2022;13:908230. https://doi.org/10.3389/fphys.2022.908230.